These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8451463

  • 1. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models.
    Fisher JW, Allen BC.
    Risk Anal; 1993 Feb; 13(1):87-95. PubMed ID: 8451463
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans.
    Allen BC, Fisher JW.
    Risk Anal; 1993 Feb; 13(1):71-86. PubMed ID: 8451462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Dose-response analyses of the carcinogenic effects of trichloroethylene in experimental animals.
    Rhomberg LR.
    Environ Health Perspect; 2000 May; 108 Suppl 2(Suppl 2):343-58. PubMed ID: 10807564
    [Abstract] [Full Text] [Related]

  • 10. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse.
    Fisher JW, Gargas ML, Allen BC, Andersen ME.
    Toxicol Appl Pharmacol; 1991 Jun 15; 109(2):183-95. PubMed ID: 2068722
    [Abstract] [Full Text] [Related]

  • 11. Trichloroacetic acid: updated estimates of its bioavailability and its contribution to trichloroethylene-induced mouse hepatomegaly.
    Chiu WA.
    Toxicology; 2011 Jul 29; 285(3):114-25. PubMed ID: 21549800
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A physiologically based pharmacokinetic model for trichloroethylene in the male long-evans rat.
    Simmons JE, Boyes WK, Bushnell PJ, Raymer JH, Limsakun T, McDonald A, Sey YM, Evans MV.
    Toxicol Sci; 2002 Sep 29; 69(1):3-15. PubMed ID: 12215655
    [Abstract] [Full Text] [Related]

  • 14. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats.
    Dallas CE, Gallo JM, Ramanathan R, Muralidhara S, Bruckner JV.
    Toxicol Appl Pharmacol; 1991 Sep 01; 110(2):303-14. PubMed ID: 1891776
    [Abstract] [Full Text] [Related]

  • 15. Tissue dosimetry expansion and cross-validation of rat and mouse physiologically based pharmacokinetic models for trichloroethylene.
    Keys DA, Bruckner JV, Muralidhara S, Fisher JW.
    Toxicol Sci; 2003 Nov 01; 76(1):35-50. PubMed ID: 12915716
    [Abstract] [Full Text] [Related]

  • 16. Trichloroethylene risk assessment: a review and commentary.
    Jollow DJ, Bruckner JV, McMillan DC, Fisher JW, Hoel DG, Mohr LC.
    Crit Rev Toxicol; 2009 Nov 01; 39(9):782-97. PubMed ID: 19852561
    [Abstract] [Full Text] [Related]

  • 17. Presystemic elimination of trichloroethylene in rats following environmentally relevant oral exposures.
    Liu Y, Bartlett MG, White CA, Muralidhara S, Bruckner JV.
    Drug Metab Dispos; 2009 Oct 01; 37(10):1994-8. PubMed ID: 19581386
    [Abstract] [Full Text] [Related]

  • 18. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites.
    Fisher JW.
    Environ Health Perspect; 2000 May 01; 108 Suppl 2(Suppl 2):265-73. PubMed ID: 10807557
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.